Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT
Recruiting
N/A
Interventional Study
Major Depressive Disorder
Bipolar Disorder
Schizophrenia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 20 (estimated)
- Sponsor
- Medipol University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective, open-label clinical trial aims to compare a novel "Venous Tourniquet with Regional Low-Dose Sugammadex" method against the gold standard "Arterial Tourniquet" (Isolated Forearm Technique - IFT) for monitoring motor seizure activity during Electroconvulsive Therapy (ECT). Using a within-subject (intra-individual) design, each of the 40 enrolled patients will receive an arterial to…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients scheduled for elective Electroconvulsive Therapy (ECT).
* ASA (American Society of Anesthesiologists) physical status I to III.
Exclusion Criteria:
* Known neuromuscular diseases (e.g., Myasthenia Gravis).
* Known allergy or hypersensitivity to sugammadex, rocuroniu…
Contacts
No contact information available.